Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Covington
Mallinckrodt
Healthtrust
Express Scripts
Merck
McKinsey
Boehringer Ingelheim

Generated: September 19, 2018

DrugPatentWatch Database Preview

ELSPAR Drug Profile

« Back to Dashboard

Summary for Tradename: ELSPAR

US Patents for ELSPAR

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Midwest Research Institute (Kansas City, MO) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Tanabe Seiyaku Co., Ltd. (Osaka, JA) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up W. R. Grace & Co. (New York, NY) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up W. R. Grace & Co. (New York, NY) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up W. R. Grace & Co. (New York, NY) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for ELSPAR

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB96/053 United Kingdom ➤ Sign Up PRODUCT NAME: DOXORUBICIN SULPHATE; REGISTERED: UK EU/1/96/011/001 19960621; UK EU/1/96/011/002 19960621
2007 00027 Denmark ➤ Sign Up PRODUCT NAME: PERFLUTREN-HOLDIGE LIPIDMIKROSAERER
/2007 Austria ➤ Sign Up PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
60031 Netherlands ➤ Sign Up PRODUCT NAME: DOXORUBICINESULFAAT VERKREGEN UIT DOXORUBICINEHYDROCHLORIDE EN AMMONIUMSULFAAT; REGISTRATION NO/DATE: EU/1/96/011/001 - EU/1/96/011/002 19960621
C/GB07/031 United Kingdom ➤ Sign Up PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Argus Health
Merck
Accenture
US Army
Farmers Insurance
Moodys
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.